Information Provided By:
Fly News Breaks for July 13, 2017
MGLN
Jul 13, 2017 | 10:57 EDT
Jefferies analyst David Styblo believes Magellan Health paid a reasonable price for Senior Whole Health while the deal will allow it to expand into new markets. Senior Whole's financial profile is "strong" and should be "meaningfully accretive" to Magellan, Styblo tells investors in a research note. He keeps a Buy rating on the shares with an $88 price target.
News For MGLN From the Last 2 Days
There are no results for your query MGLN